• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-S
Device Problem Leak/Splash (1354)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 11/14/2023
Event Type  Injury  
Event Description
The manufacturer was informed that on (b)(6) 2023, a patient was having a redo avr/cabg.The original prosthesis (unknown model, size 25) was explanted, and a complete debridement was performed.Then, sizing was started with the small sizer.The small sizer was falling through the annulus on the clear end and just barely catching on the opaque end.As such, they moved to medium sizer where the clear end was just barely catching, and the opaque end would not go through the annulus at all.As such, they went back and forth with the sizers 1 or 2 more times, and decided to proceed with size small perceval plus valve.Thus, collapsing was started while the surgeon began to place the guiding sutures.After the small valve was collapsed appropriately, deployment began.After the valve was deployed, checks were performed and ballooned with warm saline; and further checks were performed again.Surgeon stated that the guiding suture could be seen on the non-coronary cusp.It was recommended to take it out and re-implant, but this did not happen as they stated that it did not matter where the guiding suture was because it was a redo and as long as it was seated, they could make the annulus anywhere they wanted.While doing leak tests, it was noticed that the leaflets were slightly more open than normal, but the consensus was that the possible trace central leak would go away.At this point the valve was checked on echo quickly before completing the concomitant cabg.The long and short axis views looked good and did not show signs of leaks with the minimal volume in the heart.The surgeon then completed the procedure.After the clamp was off, it did not appear to be any issues.The left ventricle was not blowing up in size.However, when it got more volume, it showed a major central leak and had to go back on cross clamp to explant the perceval plus valve.It was then decided to implant a magna-ease valve instead and complete the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
MDR Report Key18330146
MDR Text Key330549277
Report Number3019892983-2023-01023
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000795
UDI-Public(01)00896208000795(240)PVF-S(17)270202
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 11/14/2023,12/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVF-S
Device Catalogue NumberPVF-S
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/14/2023
Device Age9 MO
Event Location Hospital
Date Report to Manufacturer11/14/2023
Date Manufacturer Received11/14/2023
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-